- Home
- SDGR vs BHLB Comparison
SDGR vs BHLB Comparison
Compare SDGR & BHLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- BHLB
- Stock Information
- Founded
- SDGR 1990
- BHLB 1846
- Country
- SDGR United States
- BHLB United States
- Employees
- SDGR N/A
- BHLB N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- BHLB Banks
- Sector
- SDGR Health Care
- BHLB Finance
- Exchange
- SDGR Nasdaq
- BHLB Nasdaq
- Market Cap
- SDGR 1.8B
- BHLB N/A
- IPO Year
- SDGR 2020
- BHLB 2000
- Fundamental
- Price
- SDGR $21.93
- BHLB $25.75
- Analyst Decision
- SDGR Buy
- BHLB Hold
- Analyst Count
- SDGR 7
- BHLB 5
- Target Price
- SDGR $32.29
- BHLB $32.70
- AVG Volume (30 Days)
- SDGR 1.1M
- BHLB 512.5K
- Earning Date
- SDGR 04-30-2025
- BHLB 04-17-2025
- Dividend Yield
- SDGR N/A
- BHLB 2.80%
- EPS Growth
- SDGR N/A
- BHLB N/A
- EPS
- SDGR N/A
- BHLB 1.43
- Revenue
- SDGR $207,539,000.00
- BHLB $376,001,000.00
- Revenue This Year
- SDGR $28.69
- BHLB $31.78
- Revenue Next Year
- SDGR $14.95
- BHLB $80.63
- P/E Ratio
- SDGR N/A
- BHLB $18.00
- Revenue Growth
- SDGR N/A
- BHLB N/A
- 52 Week Low
- SDGR $16.67
- BHLB $20.50
- 52 Week High
- SDGR $29.15
- BHLB $32.36
- Technical
- Relative Strength Index (RSI)
- SDGR 47.81
- BHLB 28.54
- Support Level
- SDGR $19.48
- BHLB $25.67
- Resistance Level
- SDGR $21.90
- BHLB $26.33
- Average True Range (ATR)
- SDGR 1.65
- BHLB 0.61
- MACD
- SDGR -0.04
- BHLB -0.24
- Stochastic Oscillator
- SDGR 51.20
- BHLB 2.61
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.